FindTrial
Sign In

Pharmacokinetics of Amrtottaram Kashayam in Healthy Volunteers

Pharmacokinetics of Amrtottaram Kashayam through Metabolomic Profiling using LCMS/MS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100120
Enrollment
5
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sandrima Priya Sanjeevan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volounteers willing to give written consent, No history of cardiac, hepatic, renal, haematological or psychiatric illness, with normal lab values of CBC, RFT, LFT, Blood sugar levels, not under any medication or supplementation at least for two weeks prior to the study. No acute infection or fever in the last two weeks. Non smokers and non-alcoholics

Exclusion criteria

Exclusion criteria: Pregnant women, lactating mothers, history of HTN, DM, Dyslipidaemia, Hyper and Hypothyroidism, recent vaccination within one month

Design outcomes

Primary

MeasureTime frame
Metabolomic profile of Gallic acid, Quinic acid and Quercetin 3-rhamnoside in the blood plasma through LC-MS/MSTimepoint: 0th hour, 30 minutes, 1st, 2nd, 4th, 8th, 12th, 24th and 48th hours—

Secondary

MeasureTime frame
Metabolomic profile of Gallic acid, Quinic acid and Quercetin 3-rhamnoside in urine samples through LC-MS/MSTimepoint: 0-2 hrs, 2-4 hrs, 4-8 hrs, 8-12 hrs—

Countries

India

Contacts

Public ContactMadhu K P

Vaidyaratnam P S Varier Ayurveda College

madhusukrutham@gmail.com09745994515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026